Colin J. Meyer
2020
In 2020, Colin J. Meyer earned a total compensation of $4.2M as Chief Research and Development Officer and Executive Vice President at REATA PHARMACEUTICALS, a 94% increase compared to previous year.
Compensation breakdown
| Bonus | $381,400 |
|---|---|
| Option Awards | $3,338,169 |
| Salary | $513,951 |
| Total | $4,233,520 |
Meyer received $3.3M in option awards, accounting for 79% of the total pay in 2020.
Meyer also received $381.4K in bonus and $514K in salary.
Rankings
In 2020, Colin J. Meyer's compensation ranked 2,688th out of 13,090 executives tracked by ExecPay. In other words, Meyer earned more than 79.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,688 out of 13,090 | 80th |
Division Manufacturing | 1,030 out of 5,620 | 82nd |
Major group Chemicals And Allied Products | 378 out of 2,253 | 83rd |
Industry group Drugs | 326 out of 1,953 | 83rd |
Industry Pharmaceutical Preparations | 237 out of 1,458 | 84th |
Pay ratio
| Colin J. Meyer's Pay | $4,233,520 |
|---|---|
| Median Employee's Pay | $568,580 |
| Pay Ratio | 7to 1 |
In 2020, the annual total compensation of Colin J. Meyer was $4,233,520.
The annual total compensation of the median employee at REATA PHARMACEUTICALS was $568,580.
The ratio of Colin J. Meyer's pay to the pay of median employee was therefore 7 to one.
Source: SEC filing on April 30, 2021.
Meyer's colleagues
We found four more compensation records of executives who worked with Colin J. Meyer at REATA PHARMACEUTICALS in 2020.
News
REATA PHARMACEUTICALS CEO J Huff's 2021 pay falls 37% to $4M
April 29, 2022
REATA PHARMACEUTICALS CEO J Huff's 2020 pay rises 15% to $6.4M
April 30, 2021
REATA PHARMACEUTICALS CFO Manmeet Soni receives $13M in 2019
April 29, 2020
REATA PHARMACEUTICALS CEO J Huff's 2018 pay falls 82% to $935K
April 30, 2019